| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444998 | European Journal of Cancer | 2013 | 8 Pages |
Abstract
Relapses in HB are rare events occurring in less than 12% of pts after CR. Combined treatment with chemotherapy and surgical removal of the tumour is essential for long-term survival.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M. Semeraro, S. Branchereau, R. Maibach, J. Zsiros, M. Casanova, P. Brock, C. Domerg, D.C. Aronson, A. Zimmermann, V. Laithier, M. Childs, D. Roebuck, G. Perilongo, P. Czauderna, L. Brugieres,